Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression Profiling
- 1 February 2005
- journal article
- molecular oncology
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (4) , 732-740
- https://doi.org/10.1200/jco.2005.05.145
Abstract
Purpose To discover a set of markers predictive for the type of response to endocrine therapy with the antiestrogen tamoxifen using gene expression profiling. Patients and Methods The study was per...Keywords
This publication has 25 references indexed in Scilit:
- A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifenPublished by Elsevier ,2004
- Expression Profiling of Purified Normal Human Luminal and Myoepithelial Breast CellsCancer Research, 2004
- Profiling of Estrogen Up- and Down-Regulated Gene Expression in Human Breast Cancer Cells: Insights into Gene Networks and Pathways Underlying Estrogenic Control of Proliferation and Cell PhenotypeEndocrinology, 2003
- Serum HER-2/neu and Response to the Aromatase Inhibitor Letrozole Versus TamoxifenJournal of Clinical Oncology, 2003
- Tamoxifen: a most unlikely pioneering medicineNature Reviews Drug Discovery, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Exploring the new world of the genome with DNA microarraysNature Genetics, 1999
- Tamoxifen in the Treatment of Breast CancerNew England Journal of Medicine, 1998